Semaglutide is an FDA-approved medication that has shown promising results for weight loss in clinical trials
Semaglutide has a half-life of about 7 days , meaning it can take several weeks to clear from the system
Cleaning product fumes hit first, then synthetic fragrances from the laundry aisle
In the Phase 2 trial, most of the weight loss occurred after participants reached the 8mg or 12mg target dose
51-OR: a phase 2, randomized, double-blind, placebo-controlled, dose-finding study of BI 456906 in people with overweight/obesity
A prescription written under the diabetes-approved name may be processed differently by insurance than the same drug prescribed under its weight-management brand, even though the medication itself is identical